Hello, and welcome to the annual meeting of shareholders of The Campbellās Company. Please note that todayās meeting is being recorded. During the meeting, we will have two question-and-answer sessions. The first will address questions related to the formal agenda items, and the second will address questions related to the operations of the company. Shareholders who signed in with a 15-digit control number may submit questions or comments at any time by clicking on the Q&A icon at the top of your screen. It is now my pleasure to turn todayās meeting over to Keith McLoughlin, Chairman of the Board of Directors of the company. Mr. McLoughlin, the floor is yours.
Thank you, operator, and good morning, ladies and gentlemen. Iām Keith McLoughlin, Chair of the Board of Directors, and on behalf of The Campbellās Company, welcome to the 2026 Annual Meeting of Shareholders. I am pleased to convene the meeting. I would like to introduce those with me today: Mick Beekhuizen, President and Chief Executive Officer; Charlie Brawley, Executive Vice President, General Counsel, and Corporate Secretary; and Todd Cunfer, Executive Vice President and Chief Financial Officer. All of the incumbent directors who were nominated for re-election by The Campbellās Board are participating today via electronic means. In addition to myself, let me introduce the director nominees by name: Fabiola Arredondo, Howard Averill, Mick Beekhuizen, Bennett Dorrance Jr., Grant Hill, Tessa Hilado, Sarah Hofstetter, Marc Lautenbach, Mary Alice Malone Jr., Kurt Schmidt, and Archie van Beuren. Information about all of the nominees can be found in the proxy statement.
Adela Forsyth, an employee of Computershare, is serving as Inspector of Election, and Charlie Brawley, Executive Vice President, General Counsel, and Corporate Secretary of the company, will act as Secretary of the Meeting. The companyās independent audit is performed and certified by the independent registered public accounting firm of PricewaterhouseCoopers LLP. Ray Lamb and Timothy McGrath of PricewaterhouseCoopers are present today. Although they have declined to make a statement, they will be available to answer questions regarding the fiscal 2026 audit during the general question-and-answer session later this morning. The Inspector of Election has in her possession an affidavit of mailing attesting that notice of this meeting was duly given. The Inspector of Election has also reported that more than the majority of shares required for a quorum, as specified in the bylaws, are present either in- person or by proxy.
Accordingly, a quorum is present, and the meeting is in order to proceed. Let me give a brief overview of how we plan to conduct the meeting. The proposals will be presented in the order outlined in our notice of meeting and proxy statement. We have four management proposals and one shareholder proposal. The proposals are: one, the election of 12 directors; two, the ratification of the independent registered public accounting firm for fiscal 2027; three, an advisory vote on fiscal 2026 executive compensation, also known as say-on-pay; four, a vote on an amendment and restatement of the companyās 2022 Long-Term Incentive Plan; and five, a shareholder proposal regarding a report on the effectiveness of our regenerative agriculture program, including pesticide reduction outcomes. Following consideration of the formal agenda items, we will answer any questions submitted online regarding the formal agenda items.
We will then report the results of the vote. After we adjourn the formal part of the meeting, as time permits, we will answer questions submitted online regarding the operations of The Campbellās Company. Shareholders who sign in with a 15-digit control number may submit questions by clicking on the Q&A icon at the top of the annual meeting website at any time during the meeting. If you wish to submit a question online regarding the formal agenda items, please note the proposal number to which it relates. Posted on the annual meeting website is an agenda that includes a list of the nominees for Director and the resolutions for the other agenda items. The rules for the conduct of the meeting are also posted on the annual meeting website. It is our experience that your adherence to these rules will enhance the overall effectiveness of the meeting.
The minutes of the 2025 annual meeting are available for inspection by shareholders upon request. Accordingly, may I have a motion to waive the reading of those minutes and approve them as presented?
Mr. Chair, I so move.
I second.
All those in favor? Opposed? The motion is passed. The minutes are duly approved. Thank you. Now, we will introduce the items of business to be brought before the meeting. Polls for voting are open on the annual meeting website. You may vote by clicking on the icon at the top of your screen on the annual meeting website entitled Vote. Shareholders who have already voted by proxy do not need to submit electronic ballots unless you want to change your vote. The first proposal is the election of the 12 director nominees. Directors are elected for a one-year term. The names of such persons have been placed in nomination, and because the Secretary has not received any notice of shareholder nominees, I declare that the nominations are closed. The Board of Directors unanimously recommends that shareholders vote for the 12 director nominees named in the proxy statement.
The second item on the agenda is the ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2027. The Board of Directors unanimously recommends that shareholders vote for this proposal. The third item on the agenda is the advisory vote on fiscal 2026 executive compensation. The SEC requires that shareholders be given the opportunity to cast an advisory vote on executive compensation. As an advisory vote, the outcome is not binding, but it does give shareholders the opportunity to express their views on executive compensation during a given fiscal year. The Board of Directors unanimously recommends that shareholders vote for this proposal. The fourth item on the agenda is the amendment and restatement of The Company's 2022 Long-Term Incentive Plan. The Board of Directors unanimously recommends that shareholders vote for this proposal. This brings us to the shareholder proposal.
The fifth item on the agenda is a shareholder proposal submitted by As You Sow on behalf of Sarah Gourevitch regarding a report on the effectiveness of our regenerative agriculture program, including pesticide reduction outcomes. We will now connect with Cole Genge, a representative of As You Sow, to present the proposal. Out of respect for other shareholders in attendance and to allow time for Q&A, we ask you, Mr. Genge, to limit your comments to a period of three minutes and restrict your comments to the proposal before the meeting. I will now ask the operator to unmute the line and allow Mr. Genge to present his proposal.
Mr. Genge, your line is now open.
Good morning, Mr. Beekhuizen and members of the board. My name is Cole Genge, Senior Director of Programs at As You Sow. Thank you for the opportunity to present proposal number five on the proxy on behalf of Sarah Gourevitch. This proposal asks The Campbellās Company to disclose the success of its regenerative agriculture program by reporting its outcomes, including but not limited to pesticide reduction. By touting the benefits of its program without measuring or disclosing outcomes, the company is susceptible to reputational and litigation risks, including greenwashing. A fundamental principle of regenerative agriculture is soil health, a cornerstone of natural capital. Pesticide use, which degrades healthy soil, can harm farm and supply chain resilience, in turn raising commodity prices and raising long-term viability concerns for our company.
Pesticide use can also result in the poisoning of farm workers, and pesticide drift can reach nearby communities and elementary schools, causing serious health conditions like asthma and cancer. Biodiversity, pollinator health, and air and water quality also suffer as a result of pesticide use. While our company claims its regenerative agriculture initiative focuses on advancing core regenerative principles with the goal of scaling soil health, it fails to include pesticide reduction as a key component. Campbell's also fails to measure and report pesticide use reduction by its suppliers, leaving shareholders unable to determine whether the company's program is successful in regenerating soil health and reducing harm to humans and the environment. Meanwhile, Campbell's competitors, Conagra and Lamb Weston, are publicly reporting the amount of pesticide use or avoided to demonstrate the success of their regenerative agriculture programs.
As a leading food manufacturer, Campbell's has the ability to engage its suppliers and collect and disclose pesticide data. Disclosing such data can demonstrate the success of its program, the resilience of its supply chain, and the avoidance of risk associated with harmful pesticide use. We look to the company to provide investors with this key information so they can make informed investment decisions. We urge a yes vote on this resolution. Thank you.
Mr. Genge, you're now muted.
Thank you, Mr. Genge. After careful consideration, the Board has determined that adopting this proposal is not in the best interest of the company or its shareholders. The Board believes that producing a separate prescriptive report disclosing if and how the company intends to measure and disclose the effectiveness of its regenerative agriculture program, including pesticide reduction outcomes, would be duplicative, add cost, and could divert resources from advancing grower participation and progress. The company already measures and publicly reports meaningful information regarding its regenerative agriculture and responsible pest management programs. For more information regarding the board's position on this proposal, please see the board's full statement in opposition, which is available on page 83 of the company's proxy statement. The board unanimously recommends a vote against this proposal. This completes the proposals. I will now open the meeting up for questions related to the formal agenda items.
Seeing that no questions have been submitted regarding the formal agenda items, we will now proceed to voting. If you have not voted, please do so now. The Inspector of Election will now take charge of the polls. Since it appears that all those who desire to vote have done so, the polls are now closed. I will now ask the Secretary to report the preliminary voting results.
Mr. Chair, I have received the preliminary voting results from the Inspector of Election. The Inspector has determined that based on the votes cast and received, that each of the Director nominees set forth in the proxy statement has been elected for a one-year term, that the ratification of the appointment of PricewaterhouseCoopers, the advisory resolution on fiscal 2026 executive compensation, and the amendment and restatement of the 2022 Long-Term Incentive Plan all have been approved. The shareholder proposal regarding a report on the effectiveness of our regenerative agricultural program, including pesticide reduction outcomes, was not approved. We will be reporting final voting results in a Form 8-K filed with the U.S. Securities and Exchange Commission within four business days after this meeting.
Thank you, Charlie. There being no additional business to come before this meeting, I declare this meeting adjourned. I will now ask Mick Beekhuizen, our President and Chief Executive Officer, to make a brief statement, and we will then respond to questions submitted relating to the business or operations of the company. Please refer to the non-GAAP reconciliation document posted on the annual meeting website to find reconciliations of non-GAAP measures that we may use when discussing the company's financial results.
Thank you, Keith. Good morning, everyone. Please note that the remarks will include forward-looking statements and non-GAAP financial measures. Please see our SEC filings for factors that could affect our cautionary statements. You can find the GAAP to non-GAAP reconciliations for this presentation on the Campbell's Investor Relations website. I will begin with our financial performance. Our fiscal 2026 results reflected the dynamic external operating environment, including continued volume challenges and input cost inflation. For the full year, net sales were $9.7 billion, a 5% decline versus the prior year, primarily driven by the extra week in the prior year and organic volume declines, which were only partially offset by positive net price realization. By division, organic net sales declined 1% in Meals & Beverages and decreased by 4% in Snacks.
Adjusted EBIT declined 21%, primarily driven by lower gross margins as a result of elevated cost inflation and the impact from tariffs. Productivity was a partial offset. In addition, in fiscal 2026, we delivered $80 million of enterprise cost savings, bringing total savings under our $375 million program to $225 million. Fiscal 2026 Adjusted EPS decreased 27% to $2.17, primarily reflecting lower Adjusted EBIT. Despite profit pressures, we continue to generate strong operating cash flow at $1 billion. We invested over $360 million in CapEx while returning $496 million to shareholders, including $470 million in dividends. In response to the current environment and in order to return our company to a stronger top and bottom line profile, we have made a series of changes to our organization, including strengthening our leadership team and streamlining our category-led operating model.
The goal is to enable clearer decision rights, sharpen our focus, enhance execution, and install a culture of urgency and accountability. Leveraging this team, we are investing in new and expanded capabilities across the organization. Our top priority today is to get close to the consumer in everything we do, including the products we offer, the innovation we launch, and the nutritional benefits we deliver, and the way we manufacture and bring products to market. We are focusing our marketing investments on our best opportunities and adding new capabilities while accelerating our shift towards digital. To fund these investments while protecting our margins, we have launched a new $500 million enterprise-wide savings program. The goal is to increase speed and accountability while improving our margins and cash flow. Finally, we took action to strengthen our balance sheet and reduce leverage, including resetting our dividend.
In fiscal 2027, we will invest in important growth opportunities, including our brands related to semi-scratch cooking, as well as priority Snacks brands, including Goldfish and Pepperidge Farm. At the same time, we will drive productivity and cost savings while leveraging net price realization initiatives with the goal of stabilizing and beginning to rebuild our margins. Together, our actions to focus on the consumer, strengthen our team, and improve execution are designed to restore growth, rebuild margins, reduce leverage, and position Campbell's for sustainable long-term value creation. With that, I will close my remarks and would like to answer any questions that you may have. Since no questions have been asked, I will now turn the meeting back over to our Chairman.
Thank you, Mick. Thank you to our shareholders and other guests for attending this year's annual meeting. With there being no additional business to discuss, the meeting is now concluded. Wish you all a pleasant day.
This concludes the meeting. You may now disconnect.